• (PLX AI) – Bayer says BlueRock Therapeutics names n ew Board Chair, President and CEO.
  • • Emile Nuwaysir, Ph.D., current President and CEO, will transition to the position of BlueRock Board Chair, effective August 1, 2021
  • • Current Chief Scientific Officer Seth Ettenberg, Ph.D., will asume the role of President and CEO

Quelle: PLX AI